Allergy Therapeutics (AGY) — Free Cash Flow Generation Index
Allergy Therapeutics (AGY) has a Free Cash Flow Generation Index of 0.69x as of December 2021. Free cash flow of GBX2.56 Million represents 1% of operating cash flow (GBX3.71 Million). Explore how much does Allergy Therapeutics reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Allergy Therapeutics Free Cash Flow Generation Index (2003–2021)
Historical FCF Generation Index trend for Allergy Therapeutics across 11 annual periods. For the full cash flow conversion analysis, see Allergy Therapeutics cash flow conversion.
Annual Free Cash Flow Generation for Allergy Therapeutics (2003–2021)
Year-by-year Free Cash Flow Generation Index for Allergy Therapeutics. Check Allergy Therapeutics cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (GBX) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.70x | GBX5.95 Million | GBX8.52 Million | GBX2.56 Million | ▼ -11.8% |
| 2020 | 0.79x | GBX9.73 Million | GBX12.28 Million | GBX2.55 Million | ▲ +59.1% |
| 2019 | 0.50x | GBX2.79 Million | GBX5.60 Million | GBX2.81 Million | ▲ +106.7% |
| 2017 | -7.43x | GBX-1.32 Million | GBX178.00K | GBX1.50 Million | ▼ -1241.5% |
| 2015 | 0.65x | GBX2.03 Million | GBX3.12 Million | GBX1.09 Million | ▲ +10.9% |
| 2014 | 0.59x | GBX1.27 Million | GBX2.17 Million | GBX898.00K | ▼ -11.4% |
| 2013 | 0.66x | GBX1.61 Million | GBX2.43 Million | GBX821.00K | ▲ +17.8% |
| 2012 | 0.56x | GBX1.62 Million | GBX2.88 Million | GBX1.26 Million | ▲ +23819.6% |
| 2010 | 0.00x | GBX4.00K | GBX1.70 Million | GBX1.70 Million | ▼ -99.6% |
| 2004 | 0.60x | GBX1.15 Million | GBX1.91 Million | GBX760.00K | ▼ -25.4% |
| 2003 | 0.81x | GBX1.69 Million | GBX2.10 Million | GBX406.00K | — |